A phase II trial of gemcitabine and docetaxel in patients with chemotherapy-naive, advanced nonsmall cell lung carcinoma (Q33344553)

26 July 2017

title

A phase II trial of gemcitabine and docetaxel in patients with chemotherapy-naive, advanced nonsmall cell lung carcinoma (English)

1 reference

26 July 2017

main subject

phase II clinical trial

0 references

1 reference

1 reference

Irina E Popa

1

1 reference

26 July 2017

Kathleen Stewart

series ordinal

2

1 reference

26 July 2017

Frederick P Smith

series ordinal

3

1 reference

26 July 2017

Naiyer A Rizvi

series ordinal

4

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

26 July 2017

number of pages

6

1 reference

inferred from page(s)

published in

Cancer

1 reference

26 July 2017

volume

95

1 reference

26 July 2017

issue

8

1 reference

26 July 2017

page(s)

1714-1719

1 reference

26 July 2017

cites work

Cancer statistics, 2001

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10843

Chemotherapy vs supportive care in advanced non-small-cell lung cancer. Results of a meta-analysis of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10843

Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10843

Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10843

Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10843

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10843

Phase I and pharmacokinetic study of two sequences of gemcitabine and docetaxel administered weekly to patients with advanced cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10843

Fatal pulmonary toxicity resulting from treatment with gemcitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10843

Capillary protein leak syndrome appears to explain fluid retention in cancer patients who receive docetaxel treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10843

Severe interstitial pneumonitis associated with docetaxel administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10843

Dose-finding, pharmacokinetic and phase II study of docetaxel in combination with gemcitabine in patients with inoperable non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10843

Severe pulmonary toxicity in patients treated with a combination of docetaxel and gemcitabine for metastatic transitional cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10843

Front-line treatment of advanced non-small-cell lung cancer with docetaxel and gemcitabine: a multicenter phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10843

Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10843

Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10843

Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10843

7 January 2021

Fatal pulmonary failure complicating high-dose cytosine arabinoside therapy in acute leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10843

7 January 2021

Gemcitabine and paclitaxel associated pneumonitis in non-small cell lung cancer: report of a phase I/II dose-escalating study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10843

7 January 2021

Treatment of patients with advanced nonsmall cell lung carcinoma using docetaxel and gemcitabine plus granulocyte-colony stimulating factor

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.10843

7 January 2021

Identifiers

DOI

10.1002/CNCR.10843

1 reference

26 July 2017

1 reference